Akeso Biopharma raises $250m to accelerate international clinical trials
Akeso Biopharma has successfully raised approximately $250 million through a share placement, drawing significant recognition from international investment firms. The placement saw a majority of subscribers from long-term and healthcare-focused funds, highlighting Akeso’s strong appeal in the global investment landscape. This substantial capital influx serves as a testament to Akeso’s impressive track record in drug […]
